Evidence map›Paper›PMID 40858801›Full record

ArticleCell death and differentiation2026

A novel feedback loop between DYRK2 and USP28 regulates cancer homeostasis and DNA damage signaling.

Lucía Suanes-Cobos, Irene Aguilera-Ventura, Miguel Torres-Ramos, Alejandra Serrano-Yubero, Claudia Moreno Fernández-Aliseda, Silvia Fernández, Martín Garrido-Rodríguez, Susana de la Luna, Cristian Prieto-Garcia, Markus E Diefenbacher and 2 more

Abstract read
In one paragraph

Article in Cell death and differentiation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Lucía Suanes-CobosInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.ORCID 0000-0002-9881-4015
Irene Aguilera-VenturaInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.ORCID 0009-0002-2525-9011
Miguel Torres-RamosInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.ORCID 0009-0000-2956-4203
Alejandra Serrano-YuberoInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.ORCID 0009-0005-4479-9074
Claudia Moreno Fernández-AlisedaInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.
Silvia FernándezInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.ORCID 0000-0002-3976-0512
Martín Garrido-RodríguezGenome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany.ORCID 0000-0003-4125-5643
Susana de la LunaCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.ORCID 0000-0001-7765-916X
Cristian Prieto-GarciaProtein Stability and Cancer Group, Department of Biochemistry and Molecular Biology, Theodor-Boveri-Institute, Biocenter, Würzburg, Germany.ORCID 0000-0002-7576-1061
Markus E DiefenbacherInstitute of Lung Health and Immunity, Helmholtz Center Munich, Germany and German Center for Lung Research, DZL, Munich, Germany.ORCID 0000-0002-7402-7949
Ernesto Mejías-PérezInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain.ORCID 0000-0002-5208-8177
Marco A CalzadoInstituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. mcalzado@uco.es.ORCID 0000-0002-5338-535X

Funding

Consejería de Economía, Innovación, Ciencia y Empleo, Junta de Andalucía (Ministry of Economy, Innovation, Science and Employment, Government of Andalucia) DGP_PRED_2024_00655
6 · The paper itself

Abstract

Posttranslational modifications, such as ubiquitination and phosphorylation, play pivotal roles in regulating protein stability in response to cellular stress. Dual-specificity tyrosine phosphorylation-regulated kinase 2 (DYRK2) and ubiquitin-specific peptidase 28 (USP28) are critical regulators of cell cycle progression, DNA damage response, and oncogenic signaling. However, their functional interplay remains largely unexplored. Here, we describe a novel bidirectional regulatory mechanism between DYRK2 and USP28 that integrates DNA damage response and ubiquitin-mediated protein degradation. We demonstrate that DYRK2 phosphorylates USP28, promoting its ubiquitination and proteasomal degradation in a kinase activity-independent manner, thereby contributing to the maintenance of oncogenic protein homeostasis. Conversely, USP28 functions as a deubiquitinase for DYRK2, stabilizing its protein levels and enhancing its kinase activity. Notably, we show that DYRK2 interacts and co-localizes with USP28, with the 521-541 DYRK2 region, particularly residue T525, playing a crucial role in USP28-mediated DYRK2 stabilization. Functionally, this reciprocal regulation modulates p53 signaling, influencing apoptotic responses to DNA damage. DYRK2-mediated phosphorylation of p53 at S46 is significantly reduced upon USP28 depletion, suggesting that USP28 facilitates DYRK2-dependent apoptosis. Additionally, our results highlight a complex regulatory axis involving USP28 and DYRK2, with implications for oncogenic cell death and genomic stability. Overall, our findings uncover a novel feedback loop in which DYRK2 and USP28 dynamically regulate each other to control proto-oncoprotein homeostasis and DNA damage signaling. This interplay offers potential therapeutic opportunities for targeting cancers with dysregulated ubiquitination and genomic instability.

Indexed as

DNA DamageNeoplasmsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesUbiquitin ThiolesteraseApoptosisCell Line, TumorDyrk KinasesFeedback, PhysiologicalHEK293 CellsHomeostasisHumansPhosphorylationSignal TransductionTumor Suppressor Protein p53UbiquitinationDyrk KinasesProtein Serine-Threonine KinasesProtein-Tyrosine KinasesTumor Suppressor Protein p53Ubiquitin ThiolesteraseUSP28 protein, human

Identifiers

PMID40858801
PMCPMC12811399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.